Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 1/2018

04.05.2018

Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population

verfasst von: Yunpeng Chi, Conghong Shi, Xiaojiang Zhang, Yang Xi

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

To investigate the impact of PLA2G7 polymorphism, and additional their interactions with smoking and drinking on coronary heart disease (CHD) risk based on Chinese population. GMDR model was used to screen the best gene–smoking and gene–drinking interaction combinations. Logistic regression was performed to investigate association between 4 SNPs and CHD, and the interaction effect between rs1805017 and smoking. For CHD patient–control haplotype analyses, the SHEsis online haplotype analysis software (http://​analysis.​bio-x.​cn/​myAnalysis.​php) was employed. CHD risks were higher in carriers of homozygous mutant of rs1805017 and rs1805018 than those with wild-type homozygotes, OR (95% CI) were 1.45 (1.16–1.92) and 1.51 (1.23–1.97), respectively, but the other two SNPs, rs16874954 and rs1051931 were not significant associated with CHD risks. GMDR analysis indicated that there was a significant two-locus model (p = 0.0107) involving rs1805017 and smoking, indicating a potential gene–environment interaction between rs1805017 and smoking. But we did not found any gene–drinking and gene–gene interaction combinations in GMDR models. The haplotype R-I was observed most frequently in two groups, with 47.43 and 54.38% in the case and control group of the population, respectively. The results also indicated that the haplotype containing the rs1805017-H and rs1805018-T alleles were associated with a statistically increased CHD risk, OR (95% CI) 1.43 (1.10–1.86), p = 0.0021. Polymorphisms in rs1805017 and rs1805018, additional interaction between rs1805017 and smoking, and haplotype containing the rs1805017-H and rs1805018-T alleles were associated with increased CHD risk.
Literatur
1.
Zurück zum Zitat Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757CrossRefPubMed Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757CrossRefPubMed
2.
Zurück zum Zitat Daka B, Olausson J, Larsson CA, Hellgren MI, Råstam L, Jansson PA, Lindblad U (2015) Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skovde Cohort. BMC Cardiovasc Disord 15:146CrossRefPubMedPubMedCentral Daka B, Olausson J, Larsson CA, Hellgren MI, Råstam L, Jansson PA, Lindblad U (2015) Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skovde Cohort. BMC Cardiovasc Disord 15:146CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Hu Z, Yuan X, Rao K, Zheng Z, Hu S (2014) National trend in congenital heart disease mortality in china during 2003 to 2010: a population-based study. J Thorac Cardiovasc Surg 148(2):596–602.e1CrossRefPubMed Hu Z, Yuan X, Rao K, Zheng Z, Hu S (2014) National trend in congenital heart disease mortality in china during 2003 to 2010: a population-based study. J Thorac Cardiovasc Surg 148(2):596–602.e1CrossRefPubMed
4.
Zurück zum Zitat Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield MJ, Devlin JJ, Nordio F, Hyde C, Cannon CP, Sacks F, Poulter N, Sever P, Ridker PM, Braunwald E, Melander O, Kathiresan S, Sabatine MS (2015) Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet 385:2264–2271CrossRefPubMedPubMedCentral Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield MJ, Devlin JJ, Nordio F, Hyde C, Cannon CP, Sacks F, Poulter N, Sever P, Ridker PM, Braunwald E, Melander O, Kathiresan S, Sabatine MS (2015) Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet 385:2264–2271CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041–1046CrossRefPubMed Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041–1046CrossRefPubMed
6.
Zurück zum Zitat Alkandari JR, Andersen LB, Bauman AE, Blair SN, Brownson RC, Bull FC, Craig CL, Ekelund U, Goenka S, Guthold R, Hallal PC, Haskell WL, Heath GW, Inoue S, Kahlmeier S, Katzmarzyk PT, Kohl HW 3rd, Lambert EV, Lee IM, Leetongin G, Lobelo F, Loos RJ, Marcus B, Martin BW, Owen N, Parra DC, Pratt M, Puska P, Ogilvie D, Reis RS, Sallis JF, Sarmiento OL, Wells JC (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380(9838):219–229CrossRef Alkandari JR, Andersen LB, Bauman AE, Blair SN, Brownson RC, Bull FC, Craig CL, Ekelund U, Goenka S, Guthold R, Hallal PC, Haskell WL, Heath GW, Inoue S, Kahlmeier S, Katzmarzyk PT, Kohl HW 3rd, Lambert EV, Lee IM, Leetongin G, Lobelo F, Loos RJ, Marcus B, Martin BW, Owen N, Parra DC, Pratt M, Puska P, Ogilvie D, Reis RS, Sallis JF, Sarmiento OL, Wells JC (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380(9838):219–229CrossRef
7.
Zurück zum Zitat Charniot JC, Khani-Bittar R, Albertini JP, Giral P, Cherfils C, Cosson C, Guillerm E, Leprince P, Gandjbakhch I, Bonnefont-Rousselot D (2013) Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments. Int J Cardiol 168:132–138CrossRefPubMed Charniot JC, Khani-Bittar R, Albertini JP, Giral P, Cherfils C, Cosson C, Guillerm E, Leprince P, Gandjbakhch I, Bonnefont-Rousselot D (2013) Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments. Int J Cardiol 168:132–138CrossRefPubMed
8.
Zurück zum Zitat Gao W, He HW, Wang ZM, Zhao H, Lian XQ, Wang YS, Zhu J, Yan JJ, Zhang DG, Yang ZJ, Wang LS (2012) Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis 11:55CrossRefPubMedPubMedCentral Gao W, He HW, Wang ZM, Zhao H, Lian XQ, Wang YS, Zhu J, Yan JJ, Zhang DG, Yang ZJ, Wang LS (2012) Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis 11:55CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Dada N, Kim NW, Wolfert RL (2002) Lp-PLA2: an emerging biomarker of coronary heart disease. Expert Rev Mol Diagn 2:17–22CrossRefPubMed Dada N, Kim NW, Wolfert RL (2002) Lp-PLA2: an emerging biomarker of coronary heart disease. Expert Rev Mol Diagn 2:17–22CrossRefPubMed
10.
Zurück zum Zitat Corson MA, Jones PH, Davidson MH (2008) Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker. Am J Cardiol 101:41F–50FCrossRefPubMed Corson MA, Jones PH, Davidson MH (2008) Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker. Am J Cardiol 101:41F–50FCrossRefPubMed
11.
Zurück zum Zitat Xu L, Zhou J, Huang S, Huang Y, Le Y, Jiang D, Wang F, Yang X, Xu W, Huang X, Dong C, Zhang L, Ye M, Lian J, Duan S (2013) An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A (2) and coronary heart disease. Exp Ther Med 5:742–750CrossRefPubMedPubMedCentral Xu L, Zhou J, Huang S, Huang Y, Le Y, Jiang D, Wang F, Yang X, Xu W, Huang X, Dong C, Zhang L, Ye M, Lian J, Duan S (2013) An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A (2) and coronary heart disease. Exp Ther Med 5:742–750CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Liu PY, Li YH, Wu HL, Chao TH, Tsai LM, Lin LJ, Shi GY, Chen JH (2006) Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction. J Thromb Haemost 4:1023–1028CrossRefPubMed Liu PY, Li YH, Wu HL, Chao TH, Tsai LM, Lin LJ, Shi GY, Chen JH (2006) Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction. J Thromb Haemost 4:1023–1028CrossRefPubMed
13.
Zurück zum Zitat Ninio E, Tregouet D, Carrier JL, Stengel D, Bickel C, Perret C, Rupprecht HJ, Cambien F, Blankenberg S, Tiret L (2004) Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. Hum Mol Genet 13:1341–1351CrossRefPubMed Ninio E, Tregouet D, Carrier JL, Stengel D, Bickel C, Perret C, Rupprecht HJ, Cambien F, Blankenberg S, Tiret L (2004) Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. Hum Mol Genet 13:1341–1351CrossRefPubMed
14.
Zurück zum Zitat Hong M, Zhang M, Lu X (2015) Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population. Mamm Genome 26(3–4):191–199CrossRefPubMed Hong M, Zhang M, Lu X (2015) Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population. Mamm Genome 26(3–4):191–199CrossRefPubMed
15.
16.
Zurück zum Zitat Furberg CD, Nelson JJ, Solomon C, Cushman M, Jenny NS, Psaty BM (2008) Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study. J Am Geriatr Soc 56:792–799CrossRefPubMed Furberg CD, Nelson JJ, Solomon C, Cushman M, Jenny NS, Psaty BM (2008) Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study. J Am Geriatr Soc 56:792–799CrossRefPubMed
17.
Zurück zum Zitat Persson M, Nilsson J, Nelson JJ, Hedblad B, Berglund G (2007) The epidemiology of Lp-PLA2: distribution and correlation with cardiovascular risk factors in a population-based cohort. Atherosclerosis 190:388–396CrossRefPubMed Persson M, Nilsson J, Nelson JJ, Hedblad B, Berglund G (2007) The epidemiology of Lp-PLA2: distribution and correlation with cardiovascular risk factors in a population-based cohort. Atherosclerosis 190:388–396CrossRefPubMed
18.
Zurück zum Zitat Garg PK, McClelland RL, Jenny NS, Criqui MH, Greenland P, Rosenson RS, Siscovick DS, Jorgensen N, Cushman M (2015) Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: the multi ethnic study of atherosclerosis. Atherosclerosis 241(1):176–182CrossRefPubMedPubMedCentral Garg PK, McClelland RL, Jenny NS, Criqui MH, Greenland P, Rosenson RS, Siscovick DS, Jorgensen N, Cushman M (2015) Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: the multi ethnic study of atherosclerosis. Atherosclerosis 241(1):176–182CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Wang Q, Hao Y, Mo X, Wang L, Lu X, Huang J, Cao J, Li H, Gu D (2010) PLA2G7 gene polymorphisms and coronary heart disease risk: a meta-analysis. Thromb Res 126:498–503CrossRefPubMed Wang Q, Hao Y, Mo X, Wang L, Lu X, Huang J, Cao J, Li H, Gu D (2010) PLA2G7 gene polymorphisms and coronary heart disease risk: a meta-analysis. Thromb Res 126:498–503CrossRefPubMed
20.
Zurück zum Zitat Li L, Qi L, Lv N, Gao Q, Cheng Y, Wei Y, Ye J, Yan X, Dang A (2011) Association between lipoprotein-associated phospholipase A2 gene polymorphism and coronary artery disease in the Chinese Han population. Ann Hum Genet 75:605–611CrossRefPubMed Li L, Qi L, Lv N, Gao Q, Cheng Y, Wei Y, Ye J, Yan X, Dang A (2011) Association between lipoprotein-associated phospholipase A2 gene polymorphism and coronary artery disease in the Chinese Han population. Ann Hum Genet 75:605–611CrossRefPubMed
21.
Zurück zum Zitat Hou L, Chen S, Yu H, Lu X, Chen J, Wang L, Huang J, Fan Z, Gu D (2009) Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study. Hum Genet 125:11–20CrossRefPubMed Hou L, Chen S, Yu H, Lu X, Chen J, Wang L, Huang J, Fan Z, Gu D (2009) Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: the Beijing atherosclerosis study. Hum Genet 125:11–20CrossRefPubMed
22.
Zurück zum Zitat Sutton BS, Crosslin DR, Shah SH, Nelson SC, Bassil A, Hale AB, Haynes C, Goldschmidt-Clermont PJ, Vance JM, Seo D, Kraus WE, Gregory SG, Hauser ER (2008) Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. Hum Mol Genet 17:1318–1328CrossRefPubMedPubMedCentral Sutton BS, Crosslin DR, Shah SH, Nelson SC, Bassil A, Hale AB, Haynes C, Goldschmidt-Clermont PJ, Vance JM, Seo D, Kraus WE, Gregory SG, Hauser ER (2008) Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. Hum Mol Genet 17:1318–1328CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Du W, Li Q, Lu Y, Yu X, Ye X, Gao Y, Ma J, Cheng J, Cao Y, Du J, Shi H, Zhou L (2011) Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case–control study of Chinese Han population. Endocrine 40(3):413–422CrossRefPubMed Du W, Li Q, Lu Y, Yu X, Ye X, Gao Y, Ma J, Cheng J, Cao Y, Du J, Shi H, Zhou L (2011) Genetic variants in ADIPOQ gene and the risk of type 2 diabetes: a case–control study of Chinese Han population. Endocrine 40(3):413–422CrossRefPubMed
24.
Zurück zum Zitat Luo J, Rossouw J, Margolis KL (2013) Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. JAMA 310(1):94–96CrossRefPubMedPubMedCentral Luo J, Rossouw J, Margolis KL (2013) Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. JAMA 310(1):94–96CrossRefPubMedPubMedCentral
Metadaten
Titel
Interaction between nonsynonymous polymorphisms in PLA2G7 gene and smoking on the risk of coronary heart disease in a Chinese population
verfasst von
Yunpeng Chi
Conghong Shi
Xiaojiang Zhang
Yang Xi
Publikationsdatum
04.05.2018
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 1/2018
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1671-9

Weitere Artikel der Ausgabe 1/2018

Journal of Thrombosis and Thrombolysis 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.